)
Grace Therapeutics (GRCE) investor relations material
Grace Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for September 17, 2026, with voting open until September 16, 2026 at 11:59 PM ET.
Shareholders can access proxy materials online or request paper/email copies before September 3, 2026.
Meeting will be held virtually, allowing remote participation and voting.
Voting matters and shareholder proposals
Election of five director nominees for a one-year term expiring at the 2027 annual meeting.
Advisory vote to approve executive compensation as disclosed in the proxy statement.
Ratification of KPMG LLP as independent registered public accounting firm for fiscal year ending March 31, 2027.
Advisory vote on the frequency of future say-on-pay votes, with the board recommending an annual vote.
Provision for other business to be addressed as may properly come before the meeting.
Board of directors and corporate governance
Five nominees for director: Brian Davis, Vimal Kavuru, Prashant Kohli, George Kottayil, and Edward Neugeboren.
Board recommends voting in favor of all director nominees.
- Shareholders will vote on directors, executive pay, auditor ratification, and say-on-pay frequency.GRCE
Proxy filing28 Jul 2026 - IV nimodipine could transform aSAH care by overcoming oral therapy limitations and improving outcomes.GRCE
KOL Event8 Jul 2026 - GTX-104 IV nimodipine shows superior outcomes and economic value in aSAH versus oral therapy.GRCE
Corporate presentation18 Jun 2026 - Net loss narrowed as GTx-104 advanced toward FDA resubmission, with strong trial results and IP gains.GRCE
Q4 202618 Jun 2026 - GTX-104 IV nimodipine outperformed oral therapy in aSAH, improving outcomes and reducing complications.GRCE
Corporate presentation24 Mar 2026 - IV nimodipine shows superior efficacy and compliance over oral forms for aSAH treatment.GRCE
TD Cowen 46th Annual Health Care Conference4 Mar 2026 - GTx-104 NDA accepted by FDA; net loss narrows as R&D spending drops post-Phase 3 trial.GRCE
Q3 202612 Feb 2026 - IV amlodipine shows strong clinical and economic benefits, with FDA decision expected by April 2026.GRCE
Q3 Investor Summit Group Virtual Conference 20253 Feb 2026 - GTX-104 IV nimodipine nears pivotal trial completion, targeting market launch and guideline inclusion.GRCE
H.C. Wainwright 26th Annual Global Investment Conference 202421 Jan 2026
Next Grace Therapeutics earnings date
Next Grace Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)